Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Ringpu Bio-Technology is a leading Chinese high-tech enterprise specializing in the research, development, and manufacturing of animal health products. The company provides a comprehensive portfolio including veterinary vaccines, chemical drugs, and feed additives for livestock, poultry, and companion animals. Ringpu operates several state-of-the-art manufacturing facilities and R&D centers, focusing on innovative solutions for major animal diseases such as avian influenza and swine fever. As a publicly traded company, it maintains a significant market share in China's veterinary medicine industry and is increasingly expanding into the global animal health market. The company is recognized for its integrated approach to animal disease prevention, diagnosis, and treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ruipu Biological.